Microcirculatory Changes During Magnesium Sulphate Infusion in Sepsis

Frisius Medisch Centrum14 enrolled

Overview

During infections (sepsis) bloodflow in small vessels (microcirculation) becomes disturbed. Restoration of bloodpressure and cardiac performance may not be sufficient to correct these alterations. Magnesium is a potent vasodilator which may be used to open up the small vessels, in order to reduce organ failure.

In a single-center open label study we evaluated the effects of magnesium sulphate (MgS) infusion on the sublingual microcirculation perfusion in fluid resuscitated patients with severe sepsis and septic shock within the first 48 hours after ICU admission. Directly prior to and after 1 hour of magnesium sulphate (MgS) infusion (2 gram) systemic hemodynamic variables, sublingual SDF images and standard laboratory tests, were obtained.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Severe Sepsis Septic Shock

Interventions

Magnesium SulfateDRUG

2 gram in 1 hour

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * severe sepsis and septic shock Exclusion Criteria: * pregnancy * oral bleeding * age \< 18 years * liver cirrhosis * acute arrhythmias * advanced malignancy or a mean arterial pressure (MAP) \< 65 mmHg refractory to vasopressors

Locations (1)

Hospital of Lithuanian university of health sciences

Kaunas, Lithuania

Outcomes

Primary Outcomes

microvascular flow index

Directly prior to and after 1 hour of magnesium sulphate (MgS) infusion (2 gram) systemic hemodynamic variables, sublingual SDF images and standard laboratory tests, were obtained.

Time frame: 1 hour

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.